International Journal of Coronaviruses
ISSN: 2692-1537
Current Issue
Volume No: 1 Issue No: 1
share this page

Review Article | Open Access
  • Available online freely | Peer Reviewed
  • | Provisional

    Tele-Pharmacists’ Prospects in Pandemic Situations: A Bangladesh Scenario

    Abdul Kader Mohiuddin 1      

    1Secretary and Treasurer, Dr. M. Nasirullah Memorial Trust, Tejgaon, Dhaka 1215, Bangladesh

    Abstract

    Telemedicine and telehealth technologies are especially effective during epidemic outbreaks, when health authorities recommend implementing social distance systems. Currently, coronavirus COVID-19 has affected 210 countries around the world, killed more than 200,000 and infected more than 3 million, according to worldometer, April 26, 2020. Home-care is especially important in these situations because hospitals are not seemingly safe during pandemic outbreaks. Also, the chance to get out of the home during the lockdown period is limited. Telephone-based measures improve efficiency by linking appropriate information and feedback. It can also help provide education at distance on various health issues and topics. In addition to increasing access to healthcare, telemedicine is a fruitful and proactive way to provide a variety of benefits to patients seeking healthcare; diagnose and monitor critical and chronic health conditions; improve healthcare quality and reduce costs. The article reveals scope of pharmacy professionals in telemedicine sector during epidemic outbreaks.

     

    Received 02 May 2020; Accepted 06 May 2020; Published 11 May 2020;

    Academic Editor:Sasho Stoleski, Institute of Occupational Health of R. Macedonia, WHO CC and Ga2len CC, Macedonia.

    Checked for plagiarism: Yes

    Review by:Single-blind

    Copyright©  2020 Abdul Kader Mohiuddin

    License
    Creative Commons License    This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

    Competing interests

    The authors have declared that no competing interests exist.

    Citation:

    Abdul Kader Mohiuddin (2020) Tele-Pharmacists’ Prospects in Pandemic Situations: A Bangladesh Scenario . International Journal of Coronaviruses - 1(1):19-30.
    Download as RIS, BibTeX, Text (Include abstract )
    DOI10.14302/issn.2692-1537.ijcv-20-3355

    Introduction

    Bangladesh's health care services are becoming unusually concentrated in a small fraction of costly critical health-demanding patients. A large part of these complex-patients suffers from multiple chronic diseases and are spending a lot of money. Tele-pharmacy includes patient counselling, medication review and prescription review by a qualified pharmacist for the patients who are located at a far distance from the pharmacy. The most common way to use telemedicine is a responsive model, primarily physician-led with virtual visits stimulated by alerts using interactive services, which facilitates real-time interaction between the patient and provider 1. It delivers resilience to services and enables pharmacists to work remotely, reducing the need for long journeys and increasing job satisfaction 2. The rise of pharmacists in epidemic situations has become increasingly popular in developed countries such as the United States, Australia, Canada and the United Kingdom. Along with doctors, pharmacists can serve as frontline healthcare workers during epidemics. The profession is developed and highly praised in both developed and underdeveloped countries. Millions of professional pharmacists worldwide work in various organizations, and according to data from the International Pharmaceutical Federation (FIP), nearly 75% of them work in patient care 3. Even in the United States, the continued lacking of primary health providers and medical specialists has made it possible for pharmacists to care for ambulatory patients with chronic diseases in a variety of treatment services 4. This study contributes to the existing literature by describing a telemedicine implementation for pandemic pharmacy services, which are currently nonexistent in Bangladesh.

    Methodology

    Research conducted a comprehensive month-long literature search, which included technical newsletters, newspapers and many other sources. This study started in February 2020, when the Philippines reported its first death outside China. PubMed, ALTAVISTA, Embase, Scopus, the Science Web and the Cochrane Central Register have been carefully searched. The keywords were used to search out extensively followed journals from various publishers such as Elsevier, Springer, Willey Online Library, and Wolters Kluwer. Medical and technical experts, pharmacy professionals, hospital staffs and journalists have given valuable suggestions. Projections were based on review of tele-pharmacists in both general and pandemic health situations, eligibility of pharmacists in telemedicine in general, present under-utilization scenario of Bangladeshi pharmacists in health services, let alone in telemedicine sector. Major infrastructure revolution in both pharmacy education and country’s technological advancement are necessary to build an effective telemedicine system in this country.

    Present Socio-Economic and Healthcare Situation

    Bangladesh is the seventh most populous country in the world and population of the country is expected to be nearly double by 2050 6, where communicable diseases are a major cause of death and disability 7. A recent Dengue outbreak in 2019, more than 100,000 people was affected in more than 50 districts in Bangladesh in the first 6 months of 2019 8, 9. According to World Bank's Country Environmental Analysis (CEA) 2018 report, air pollution lead to deaths of 46,000 people in yearly in Bangladesh 10. Although a riverine country, 65% of the population in Bangladesh do not have access to clean water 11. Both surface water and groundwater sources are contaminated with different contaminants like toxic trace metals, coliforms as well as other organic and inorganic pollutants 5. Studies in capital Dhaka and Khulna also found that about 80% of fecal sludge from on-site pit latrines is not safely managed 12. Nearly half of all slum dwellers of the country live in Dhaka division 13 and 35% of Dhaka's population are thought to live in slums 14. A recent research demonstrates widespread poor hygiene and food-handling practices in restaurants and among food vendors 15. Less than 10% hospitals of this country follow the Medical Waste Management Policies 16. In 2017, 26 incidents of disease outbreak were investigated by National Rapid Response Team (NRRT) of IEDCR 17. Economic development and academic flourishment do not represent development in health sector. Out of the pocket treatment cost raised nearly 70% in the last decade 18. Although, officially 80% of population has access to affordable essential drugs, there is plenty of evidence of a scarcity of essential drugs in government healthcare facilities 19. Surprisingly, the country’s pharmaceutical sector is flourishing, exports grew by more than 7% in last 8 months although total export earnings of the country drop to nearly 5% 20. It has been found in Bangladesh that more than 80% of the population seeks care from untrained or poorly trained village doctors and drug shop retailers 21. According to WHO, the current doctor-patient ratio in Bangladesh is only 5.26 to 10,000, that places the country at second position from the bottom, among the South Asian countries 22. According to World Bank data, Bangladesh has 8 hospital beds for every 10,000 people; by way of comparison, the US has 29 while China has 42 23. Tobacco is responsible for 1 in 5 deaths in Bangladesh, according to the WHO, kills more than 161,000 people on average every year. Around 85% population of age group 25-65 never checks for diabetes 24. Joint survey of the Power and Participation Research Centre and BRAC Institute of Governance and Development (PPRC-BIGD Rapid Response Survey) reveals that per capita daily income of urban slum and rural poor by drops by 80%, due to present countrywide shutdown enforced by the government to halt the spread of Covid-19. 40% to 50% of these population took loans to meet the daily expenses 25.

    Pharmacy Education in Bangladesh

    In many developing countries, including Bangladesh, pharmacy education is still limited to didactic learning which produces theoretically 'skilled' graduate professionals. Bangladesh's pharmacy curriculum doesn't really meet the minimum requirement for adequate clinical, hospital and community pharmacy education, as it is still linked to an old pharmacy model e.g. based on chemistry and basic sciences. That is present curriculum produces Pharmacist only to work in the pharmaceutical industry and jobs in this field of work is going to be saturated. No university so far have modified their curriculum including topics as epidemiology, pharmaco-economics, clinical medicines, community skills. Manpower development for community pharmacies in Bangladesh is not systematically regulated and constitute an important public health issue. Three levels of pharmacy education are currently offered in Bangladesh leading to either a university degree, a diploma or a certificate. Graduates with degrees work in industry while those with diplomas work in hospitals 26. Pharmacy is taught in about 100 public and private universities in Bangladesh and about 8000 pharmacy students graduate every year 27. Due to a lack of government policy, hospital, community, and clinical pharmacy in Bangladesh were not well developed 28. In real Bangladesh pharmacy practice areas for graduate pharmacists in industry i.e. industrial pharmacy practices, in marketing or regulatory sections are limited. The educational system of pharmacy is one of the major reasons for bounded pharmacy practices because the courses included in bachelor degree principally emphasize on industrial practices 29. Over 90% of B. Pharm curriculum emphasizes on product-oriented knowledge whereas only around 5% of the total course credits are allocated toward clinical pharmacy. This curricular framework indicates a minimum emphasis on patient care education 30. However, the graduates who pass out do not get employment easily due to their inadequate training, lack of thorough knowledge of fundamental concepts and practical skills 17. Accordingly, qualified graduates leave for overseas where they are offered more prosperous jobs. Researchers argued that pharmacy education in Bangladesh can contribute to public and private benefits if its process determines a realistic pattern 31. This system could be more beneficial to the public if the excellent hospital and community practices are introduced properly and also by involving the pharma professionals e.g. pharmacists and other skilled health care providers.

    Present State of Pandemic Situation Handling by Bangladeshi Hospitals

    More than 70% of the 7667 coronavirus cases detected in Bangladesh (as on 01, May, 2020) have been reported in Dhaka division and half of them are in capital Dhaka 32. The virus hit a total of 11 out of the 64 districts in the country until 05.04.2020 after the first known cases were reported around a month ago, according to the government’s disease control agency IEDCR 33. Amidst this global crisis, Bangladesh has been identified as one of the 25 most vulnerable countries to be affected by the fast-spreading virus. From 1st April to 14th (IEDCR update until 19.04.2020 is shown in figure 1), Covid-19 cases became 20-fold and by 30.04. 2020, it was confirmed in 63 out of 64 districts, taking the officially Covid-19 death toll to 168 34, 35. Many patients with fever, cold and breathing problems – which are also COVID-19 symptoms – have gone untreated as the hospitals in Dhaka are sending them to the IEDCR for coronavirus test 36. Many doctors are not providing services fearing the contagion and lab technicians are shunning workplaces halting medical tests, according to the patients. In some cases, serious patients who are not affected by COVID-19, moved from one hospital to the other but could not receive treatment and finally died, the media reported. In another case, the doctor fled leaving the patient behind 37, 38, 39, 40. Doctors and other healthcare workers say they do not have adequate personal protective equipment and the health system cannot cope with the outbreak 41. Police have locked down a total 52 areas of Dhaka after Covid-19 positive patients were found in the localities 42. Experts say elderly people infected with coronavirus need ICU support the most. The number of older persons in the country is over 0.8 million 43. In reality, hospitals in Bangladesh have less than 1200 ICU beds (432 govt, 737 private) in total against a population of 161.4 million people 44. The health minister on 29.03.2020 reported that there are only 500 ventilators in the country 45.

    Figure 1. The Mapping of COVID-19 Confirmed Cases in BANGLADESH, 19 April 2020 (Source: IEDCR Web).
    Figure 1.

    Underutilization of Hospital Pharmacy

    Compared with developed countries, the pharmacy profession is still lagging behind in developing countries in a way that the pharmacy professionals have never been seen as part of the health care team either by the community or by the health care providers. Though hospital pharmacists are recognized in many developed nations for their importance as a healthcare professional, in most developing countries it is still underutilized or underestimated 45, 46, 47, 48. Hospital pharmacy practice has just begun in some modern private hospitals in Bangladesh, which are inaccessible to most people because of the high cost of these hospitals to patients 49. People are totally unknown to the responsibilities of hospital pharmacist, even they don’t seek for recruit for hospital pharmacist in any hospital except a few aristocrat hospitals 50. A Dhaka survey found nearly 50% of the respondents with acute respiratory disease (ARI) symptoms identified local pharmacies as their first point of care. Licenses are provided by the Directorate-General of Drug Administration to drug sellers when they have completed a grade C pharmacy degree (i.e. 3 month course) for the legal dispensation of drugs 51 but a grade A pharmacy degree holder, having a B. Pharm or Pharm. D degree should be more equipped to handle these situations, if trained properly. Pharmacist's knowledge and helpfulness were identified as two key determinants which could not only satisfy and promote willingness to pay for the service 52. They can individualize the medications and their dosing according to the needs of the patient, which can minimize the cost of care for the medication. In Bangladesh, however, graduate pharmacists do not engage directly in-patient care. Here, pharmacies in hospitals are primarily run by non-clinically educated, diploma pharmacists 28. If the hospital pharmacy is established, patient care, proper dispensing of medications, and other patient-oriented issues can be handled properly. By maintaining a hospital pharmacy quality control program, the health sector can be enriched.

    Prospect of Pharmacists in Patient Management Service and Telehealth Care

    Pharmacists are the third largest healthcare professional group in the world after physicians and nurses 53. At present, Hospital Pharmacy has created enormous job opportunities, where graduate pharmacists play a vital role in patient rearing, rehabilitation and wellness. A professional pharmacist or a pharmacy apprentice at a clinic, hospital and community care can determine what to do in a given disease situation, if guided properly by another medical personnel 54, 55, 56. The country has a huge opportunity to recruit these pharmacists at Telehealth Care. In each call, a pharmacist can provide both appropriate and quality information from the most recent medical systems. Studies show that the lack of proper medication management leads to higher healthcare costs, longer hospital stays, morbidity and mortality. Further, it was reported that one in every five hospitalizations was related to post-discharge complications and about seventy percent were related to proper use of the drug. In 2017, the World Health Organization committed to minimizing serious, avoidable drug-related harm over the next 5 years. Pharmacists' interventions to prevent drug-related problems at three community hospitals in California saved approximately 0.8 million USD in a year 57. The estimated annual cost of medication error-based illnesses and deaths worldwide was USD 500 billion due to non-compliance with the clinical intervention and quantities in 2016. Also, the authors estimate that more than 275,000 people die every year for the same reasons 58. A pharmacist can use simple and non-medical terminology to set the goal for patients to understand the information as well as to fulfill the prescription by proper request. With chronic conditions such as cardiovascular and respiratory diseases, there is ample evidence of the effectiveness of the tele-pharmacist for remote monitoring, communication and consultation 59. In addition, psychotherapy can also be operated through telehealth as part of behavioral health 60. The pharmacy-related needs of pandemic patients have similarities with the traditional patient population, but with different emphasis 61. For example, when providing consulting services to patients, instead of focusing on medications as usual, their queries relate primarily to the knowledge of medical prevention and basic details on COVID-19, such as mask selection and standard COVID-19 signs and symptoms, symptomatic treatment options, breathing difficulties or cough management in comorbid situations, reinforcing behaviors that limit the spread of the pandemic, including social distancing and remaining in the home whenever possible through phone calls/video conferencing 62, 63. Earlier, Student pharmacists served as an effective education resource for patients regarding the H1N1 pandemic 64. Sorwar et al, 2016 revealed that the existing telemedicine service reduced cost and travel time on average by 56% and 94% respectively compared to its counterpart conventional approach with high consumer satisfaction 65.

    History of Telehealth Service in Bangladesh

    The year 1998 represents a milestone for eHealth in Bangladesh when the first eHealth project was introduced by Swinfen Charitable, a non-profit institution. It associated collaborative work between the Center for Paralyzed Rehabilitation (CRP) in Bangladesh and Haslar Royal Navy Hospital in the UK. In the same year the Ministry of Health and Family Welfare (MoHFW) launched its first initiative on eHealth 66, 67. Just a year afterward the private enterprise Telemedicine Reference Center Limited (TRCL) started providing healthcare with mobile phones. The Bangladesh Telemedicine Association (BTA), a professional coalition, was created in 2001. That has provided a platform for ongoing and sparse eHealth initiatives in the country. A similar platform, called the Sustainable Development Network Program (SDNP), was formed in 2003 with the aim of establishing better cooperation and understanding between providers 68. Later in 2006, TRCL paired with GrameenPhone (GP) and established the Health Line:789 subscriber mobile help desk 69, 70. A number of NGOs subsequently developed an interest in eHealth and mHealth, including BRAC, the Sajida Foundation and DNet 71. In addition, Bangladesh launched a toll-free national emergency aid line 999 in December 2017 to meet immediate needs in the event of any accident, crime, fire or ambulance 72. In addition, the IEDCR has launched 17 hotline numbers for the said Covid-19 outbreak 73.

    Challenges of Tele-pharmacy Implementation

    Firstly, it has limited evidence of its effectiveness beyond that of intervention by a traditional pharmacist. This favors the skepticism of both physicians and patients towards these services and limits their acceptance in the community 74. Second, the tele-pharmacy is a service based on the technology. Thus, the driver is technology but also the limiting factor for its implementation. Establishing a tele-pharmacy service involves not only meeting technological requirements but also a considerable amount of time, effort and money 75. Third, effective tele-pharmacy services should be based on standardized healthcare delivery models, and require appropriate regulations that may differ from country to country. For example, such facilities are not permitted or even restricted in some countries, while adequate legislation is available in others such as USA, Italy and other European countries 76, 77, 78, 79. Unfortunately, despite the rampant potential of tele-pharmacy in many countries, the laws and policies governing pharmacy operations do not adequately address the growing sector. Fourthly, the reluctance or inability to use advanced technologies can limit the implementation of tele-pharmacy services from the perspective of both pharmacists and patients, especially in the context of the elderly 80, 81, 82, 83, 84, 85. Fifthly, since tele-pharmacy involves the gathering, transmission and replacement of personal and health information on the web, information security and privacy are major issues. Data sharing of information collected via tele-pharmacy services with other healthcare professionals increases the possibility of security breaches. The security and integrity of patient data is therefore of paramount importance when determining the setup of a tele-pharmacy system of information technology 86, 87, 88, 89, 90, 91. Sixth, the integration of tele-pharmacy services in the national healthcare systems and the connection of tele-pharmacy services (including a combination of electronic data entry, prescription order verification, online benefit adjudication, medication dispensing) among different areas of a country requires harmonizing the healthcare systems and related governing laws and setting up proper rules and regulations 92, 93, 94. Seventh, tele-pharmacy services are not yet reimbursed: individuals are required to pay for these services, and the expenses are not covered by private or public health insurance 95, 96, 97, 98, 99. This restricts the use of these services by patients who may eventually need them.

    Overcoming Challenges

    In Bangladesh a number of telemedicine systems were introduced. Telemedicine laws and reimbursement policies since telemedicine practice is increasing on a daily basis in Bangladesh, so structured laws and regulations on doctors, patient issues, licensing of physicians and telemedicine providers are very much needed. Clear rules should be in place on questions of reimbursement. Bangladesh Television (BTV) and other satellite channels can play an important part in popularizing telemedicine. They should broadcast successful cases considering telemedicine's efficacy and cost-efficiency. Telemedicine systems and services compatibility of hardware and software require users to have compatible hardware at both ends of the communications link, which reduces interoperability and the benefits of access to different sources of telemedicine expertise. If the equipment is difficult to access or are less likely to involve practitioners. Equipment for wireless telemedicine is preferable to wire devices. Telemedicine privacy and confidentiality involves the electronic transmission of patient medical records and information from one location to another via the Internet, or other computerized media. Medical information is often delicate, confidential and private. Telemedicine, thus presents significant challenges for safeguarding the privacy and confidentiality of information about patient health. Specific privacy regulations should govern the practice of telemedicine so that patients can feel safe in knowing that confidentiality of their personal information will have to suffer certain penalties.

    Conclusion

    Overburdened by patient loads and the explosion of new drugs, physicians have increasingly turned to pharmacists for information about drugs, particularly within institutional settings. They acquire medical and medicinal history, check medication errors including prescription, dispensing and administration errors, identify drug interactions, monitor ADR, suggest dosage regimen individualization, provide patient counseling, etc. Among chronic disease patients, particularly those under quarantine, there is a greater challenge in the supply of drugs and compliance with medications, although the safety and effectiveness of care is still critical for these patients. Stronger data on the effectiveness of this area of pharmacy care, together with a critical assessment of its limitations, can raise awareness among the actors involved about its potential and could contribute to a wider dissemination of tele-pharmacy services in public interest. At the end, it can be said that pharmacists can play a role in both medical aids and regulation. But their social acceptance as a frontline patient care provider is necessary first. Similarly, in tele-healthcare, the professional pharmacist can play an essential role that has not been recognized yet due to lack of proper initiatives. We hope that policy makers of Bangladesh are aware of its potential and contribute to the wider promotion of tele-pharmacy services in the interest of the citizenry.

    Abbreviations

    IEDCR-Institute of Epidemiology, Disease Control and Research

    Acknowledgement

    I’m thankful to Dr. Colin D. Rehm, Clinical Assistant Professor, Department of Epidemiology & Population Health, Alert Einstein College of Medicine, NY, USA for her precious time to review my literature and thoughtful suggestions. Also, I’m also grateful to seminar library of Faculty of Pharmacy, University of Dhaka and BANSDOC Library, Bangladesh for providing me books, journal and newsletters.

    Financial Disclosure or Funding

    N/A

    Informed Consent

    N/A

    Author Contributions

    N/A

    References

    1.Kane-Gill S L, Niznik J D, Kellum J A.. Use of Telemedicine to Enhance Pharmacist Services in the Nursing Facility. Consult Pharm 32(2), 93-98.
    2.Pike H.Web therapy: how pharmacists are leading the way on telehealth. , The Pharmaceutical Journal 09-08.
    3.Bates I, John C, Bruno A, Fu P, Aliabadi S. (2016) An analysis of the global pharmacy workforce capacity. Published , Hum Resour Health 14(1), 61.
    4.Goode J V, Owen J, Page A, Gatewood S. (2019) Community-Based Pharmacy Practice Innovation and the Role of the Community-Based Pharmacist Practitioner in the United States. Pharmacy (Basel). Published 7(3), 106.
    5.Hasan M K, Shahriar A, Jim K U. (2019) Water pollution in Bangladesh and its impact on public health. Published , Heliyon 5(8), 10-1016.
    6.Saha S, Hossain M T. (2017) Evaluation of medicines dispensing pattern of private pharmacies in Rajshahi. Published , Bangladesh, BMC Health Serv Res 17(1), 136.
    7.Muhammad F, Chowdhury M, Arifuzzaman M, Chowdhury A A.Public Health Problems in Bangladesh: Issues and challenges. , South East Asia Journal of Public Health 6(2), 11-16.
    8.Dayaram S, Pokharel S. (2019) Bangladesh hit by worst dengue outbreak on record. CNNhealth.
    9.Mohiuddin A K.Dengue Epidemic Situation in Bangladesh. , Journal of Clinical Case Studies 4(3), 10-16966.
    10.Mohiuddin A K.Chemical Contaminants and Pollutants in the Measurable Life of Dhaka City. , European Journal of Sustainable Development Research 3(2), 0083-10.
    11.Bangladesh. (2018) MICS 2012-2013 Water Quality Thematic Report.
    12.Amin N, Rahman M, Raj S. (2019) Quantitative assessment of fecal contamination in multiple environmental sample types in urban communities in Dhaka, Bangladesh using SaniPath microbial approach. PLoS One. Published 16, 10-1371.
    13.AAA Al-Shoaibi, Matsuyama A, Khalequzzaman M.Perceptions and behavior related to noncommunicable diseases among slum dwellers in a rapidly urbanizing city. , Dhaka, Bangladesh:, Nagoya J Med Sci 80(4), 559-569.
    14.Heijden J van der, Gray N, Stringer B. (2019) Working to stay healthy', health-seeking behaviour in Bangladesh's urban slums: a qualitative study. Published , BMC Public Health 19(1), 600.
    15.Nizame F A, Alam M U, Masud A A, Shoab A K, Opel A et al. (2019) Hygiene in Restaurants and among Street Food Vendors in Bangladesh. Am J Trop Med Hyg. 101(3), 566-575.
    16.Mohiuddin A K.Medical Waste: A Nobody’s Responsibility After Disposal. , Int J Environ Sci Nat Res 15(2), 555908-10.
    17.Mohiuddin A.An A-Z Pharmaceutical Industry: Bangladesh Perspective. , Asian Journal of Research in Pharmaceutical Science 9(1), 17-28.
    18.Mohiuddin A K.Pharmaco-economics: Essential but merely practiced in Bangladesh. , Academia Journal of Scientific Research 7(3), 182-187.
    19.Husain M, Rahman M, Alamgir A, Uzzaman M S, Flora M S. (2019) Disease Surveillance System of Bangladesh: Combating Public Health Emergencies. Published , Online J Public Health Inform 11(1), 10-5210.
    20.Report Online. (2020) Export earnings drop to $26.24b in eight months. The Financial Express.
    21.Ahmed S M, Naher N, Hossain T, Rawal L B. (2017) Exploring the status of retail private drug shops in Bangladesh and action points for developing an accredited drug shop model: a facility based cross-sectional study. Published , J Pharm Policy Pract 2017, 21.
    22.Mohiuddin A K.Patient satisfaction with healthcare services: Bangladesh perspective. , International Journal of Public Health Science (IJPHS) 9(1), 34-45.
    23.Saleh A.In Bangladesh, COVID-19 threatens to cause a humanitarian crisis. World economic Forum. 06-04.
    24.Mohiuddin A K. (2019) TRACK (by NEHEP) Implementation: A Bangladesh Scenario. Pharmacovigilance and Pharmacoepidemiology. 2(1), 28-36.
    25.Mahmud N. (2020) PPRC-BIGD Survey: 52% urban, 36% rural people take loans during shutdown. DhakaTribune.
    26.Alam G, Shahjamal M, Al-Amin A, Azam M.State of Pharmacy Education in Bangladesh. , Tropical Journal of Pharmaceutical Research 12(6), 1106-10.
    27.Mazid M A, Rashid M A.Pharmacy Education and Career Opportunities for Pharmacists in Bangladesh. , Bangladesh Pharmaceutical Journal 14(1), 1-9.
    28.Saha T, Bhuiya R H, Masum Z U, Islam M R, Chowdhury J A.. Hospital Pharmacy Management System and Future Development Approaches in Bangladeshi Hospital. Bangladesh Pharmaceutical Journal 20(2), 180-187.
    29.Jakaria M. (2015) Pharmacy practices in Bangladesh. The Independent/Stethoscope.
    30.Islam M A, Gunaseelan S, Khan S A, Khatun F, Talukder R.Current challenges in pharmacy education in Bangladesh: A roadmap for the future. Currents. in Pharmacy Teaching and Learning 6(5), 730-735.
    31.Alam G M, Al-Amin A Q.Role of Pharmacy Education in National Development of Bangladesh: A Scope for Public and Private Sectors. , Indian Journal of Pharmaceutical Education and Research 48(4), 11-21.
    32.Correspondent Staff. (2020) COVID-19 detection hits 7,667, death toll 168 in. , Bangladesh. NEWAGE Bangladesh
    33.Correspondent Senior.Coronavirus cases detected in 11 districts, more than half of them in Dhaka. 24, 06-04.
    34.Likhon N. (2020) Separate plans for corona hotspot districts needed. , Bangladesh Post
    35.English Somoy. (2020) Desk. This district luckyly still free from coronavirus. , Somoy TV News Portal, April 30.
    36. (2020) The Financial Express. Entire Bangladesh is at risk:. , Health Directorate. National 16.
    37.Masum O.Dhaka hospitals turning away patients with fever, cold needing coronavirus tests. 24-19.
    38.Correspondent Staff.Health minister vows to punish private hospitals for turning away patients. 24-03.
    39.Islam Z, Mollah S.Admission to Hospitals: Patients left in quandary. The Daily Star. 24-03.
    40.Akhter F.COVID-19 and healthcare denial. , NEWAGE OPINION 02-04.
    41.DU.student ‘denied treatment by hospitals’ dies. The Financial Express/National. 07-04.
    42.Chowdhury T.Poor Bangladeshis being turned away from hospitals. , Al Jazeera America News/Bangladesh 07-04.
    43.Report Tribune.Police lock down 52 areas in Dhaka. DhakaTribune. 08-04.
    44.Abdullah M. (2020) Number of ICU beds insufficient to combat. Covid-19 pandemic. DhakaTribune .
    45.Hasan K. (2020) Healthcare professionals now face the coronavirus wrath. DhakaTribune.
    46.Azhar S, Hassali M A, Ibrahim M I, Ahmad M, Masood I et al. (2009) The role of pharmacists in developing countries: the current scenario in Pakistan. Hum Resour Health. 2009;7: 54. Published. 13, 10-1186.
    47.MHF Sakeena, Bennett A A, McLachlan A J. (2018) Enhancing pharmacists' role in developing countries to overcome the challenge of antimicrobial resistance: a narrative review. Antimicrob Resist Infect Control. 2, 63-10.
    48.MHF Sakeena, Bennett A A, McLachlan A J. (2019) The Need to Strengthen the Role of the Pharmacist in Sri Lanka: Perspectives. Pharmacy (Basel). Published 7(2), 54.
    49.Rayes I K, Hassali M A, Abduelkarem A R.The role of pharmacists in developing countries: The current scenario in the United Arab Emirates. , Saudi Pharm J 23(5), 470-474.
    50.Paul T R, Rahman M A, Biswas M, Rashid M, MAU Islam.Practice of Hospital Pharmacy in Bangladesh: Current Perspective. , Bangladesh Pharmaceutical Journal 17(2), 187-192.
    51. (2009) . The Pharmaceutical Journal. Development of Hospital Pharmacy in Bangladesh. News & analysis .
    52.Chowdhury F, Sturm-Ramirez K, Mamun A A. (2017) Factors driving customers to seek health care from pharmacies for acute respiratory illness and treatment recommendations from drug sellers in Dhaka city. Published , Bangladesh. Patient Prefer Adherence 2017, 479-486.
    53.AlShayban D M, Naqvi A A, Islam M A. (2020) Patient Satisfaction and Their Willingness to Pay for a Pharmacist Counseling Session. in Hospital and Community Pharmacies in Saudi Healthcare Settings. Front Pharmacol. 2020;11: 138. Published 2, 10-3389.
    54.Khan A N, Khan M U, Shoaib M H, Yousuf R I, Mir S A.Practice nurses and pharmacists: a perspective on the expectation and experience of nurses for future collaboration. , Oman Med J 29(4), 271-275.
    55.Jorgenson D, Dalton D, Farrell B, Tsuyuki R T, Dolovich L.Guidelines for pharmacists integrating into primary care teams. , Can Pharm J (Ott) 146(6), 342-352.
    56.Safitrih L, Perwitasari D A, Ndoen N, Dandan K L. (2019) Health Workers' Perceptions and Expectations of the Role of the Pharmacist in Emergency Units: A Qualitative Study. in Kupang, Indonesia. Pharmacy (Basel) Published 7(1), 31.
    57.Chevalier B, Neville H L, Thompson K, Nodwell L, MacNeil M.Health Care Professionals' Opinions and Expectations of Clinical Pharmacy Services on a Surgical Ward. , Can J Hosp Pharm 69(6), 439-448.
    58.Schneider P J. (2013) Evaluating the impact of telepharmacy. Am J Health Syst Pharm. 70(23), 2130-5.
    59.Watanabe J H, McInnis T, Hirsch J D. (2018) Cost of Prescription Drug-Related Morbidity and Mortality. Ann Pharmacother. 52(9), 829-837.
    60.Littauer S L, Dixon D L, Mishra V K, Sisson E M, Salgado T M.Pharmacists providing care in the outpatient setting through telemedicine models: a narrative review. Pharm Pract (Granada). 15(4), 1134-10.
    61.Langarizadeh M, Tabatabaei M S, Tavakol K, Naghipour M, Rostami A et al.Telemental Health Care, an Effective Alternative to Conventional Mental Care: a Systematic Review. Acta Inform Med. 25(4), 240-246.
    62.Zheng S Q, Yang L, Zhou P X, Li H B, Liu F et al. (2020) Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective. Res Social Adm Pharm. 10-1016.
    63.Carico RR Jr, Sheppard J, Thomas C B. (2020) Community pharmacists and communication in the time of COVID-19: Applying the health belief model [published online ahead of print. 2020-1551.
    64.Cadogan C A, Hughes C M. (2020) On the frontline against COVID-19: Community pharmacists' contribution during a public health crisis. Res Social Adm Pharm. 31, 1551-7411.
    65.Miller S, Patel N, Vadala T, Abrons J, Cerulli J. (2003) Defining the pharmacist role in the pandemic outbreak of novel H1N1 influenza. , J Am Pharm Assoc 52(6), 763-7.
    66.Sorwar G, Rahamn M M, Uddin R, Hoque M R.Cost and Time Effectiveness Analysis of a Telemedicine Service in Bangladesh. Stud Health Technol Inform. 2016, 127-134.
    67.Vassallo D J, Swinfen P, Swinfen R, Wootton R.Experience with a low-cost telemedicine system in three developing countries. , J Telemed Telecare. 2001;7 Suppl 1, 56-8.
    68.Rahman M S, Shuvo M H.. Available In: http://www.ijirset.com/upload/2015/june/131_Advancement.pdf , International Journal of Innovative Research in Science, Engineering and Technology (IJIRSET) 4(6), 4810-4822.
    69.Nessa A, Ameen M A, Ullah S, Kwak K S. (2008) Applicability of Telemedicine in Bangladesh: Current Status and Future Prospects. Third International Conference on Convergence and Hybrid Information Technology 138-145.
    70.Khatun F, Heywood A E, SMA Hanifi, Rahman M S, Ray P K et al. (2017) Gender differentials in readiness and use of mHealth services in a rural area of Bangladesh. BMC Health Serv Res. 17(1), 573-10.
    71.Ahmed T, Lucas H, Khan A S, Islam R, Bhuiya A et al. (2014) eHealth and mHealth initiatives in Bangladesh: a scoping study. BMC Health Serv Res. 16, 10-1186.
    72.Hossain M N, Okajima H, Kitaoka H, Yokota F, Ahmed A. (2018) . eHealth Consumer Behavior. International Series on Computer Entertainment and Media Technology Behavior Engineering and Applications 129-147.
    73.Online Star. (2017) Report. For emergency, dial 999. The Daily Star.
    74.Alif A. (2020) Coronavirus: Frustration rising over inadequate hotline services. DhakaTribune.
    75.Baldoni S, Amenta F, Ricci G. (2019) Telepharmacy Services: Present Status and Future Perspectives: A Review. Published , Medicina (Kaunas) 55(7), 327.
    76.Poudel A, Nissen L M. (2016) Telepharmacy: a pharmacist's perspective on the clinical benefits and challenges [published correction appears in Integr Pharm Res Pract. 10;5: 83]. Integr Pharm Res Pract Published 2016, 75-82.
    77.Mohiuddin A K.Clinical Pharmacists in Chronic Care. , Global Journal of Medical Research 2019, 1-60.
    78.Alexander E, Butler C D, Darr A, Jenkins M T, Long R D et al. (2017) . , ASHP Statement on Telepharmacy. Am J Health Syst 74(9), 10-2146.
    79.Telemedicine. (2016) The legal framework (or the lack of it). in Europe. GMS Health Technol Assess. 2016;12:Doc03. Published 16, 10-3205.
    80.Crico C, Renzi C, Graf N. (2018) mHealth and telemedicine apps: in search of a common regulation. Published , Ecancermedicalscience 2018, 853.
    81.Cimperman M, Brenčič M M, Trkman P, Stanonik Mde L.Older adults' perceptions of home telehealth services. , Telemed J E Health 19(10), 786-790.
    82.van Houwelingen CT, Ettema R G, Antonietti M G, Kort H S. (2018) Understanding Older People's Readiness for Receiving Telehealth: Mixed-Method Study. Published , J Med Internet Res 20(4), 10-2196.
    83.Evans J, Papadopoulos A, Silvers C T.Remote Health Monitoring for Older Adults and Those with Heart Failure: Adherence and System Usability. , Telemed J E Health 22(6), 480-488.
    84.Goodridge D, Marciniuk D.Rural and remote care: Overcoming the challenges of distance. , Chron Respir Dis 13(2), 192-203.
    85.Whitten P, Holtz B, Laplante C Telemedicine. (2010) What have we learned?. Published , Appl Clin Inform 1(2), 132-141.
    86.Iftikhar S, Saqib A, Sarwar M R, Sarfraz M, Arafat M et al.Capacity and willingness to use information technology for managing chronic diseases among patients: A cross-sectional study in Lahore, Pakistan. Plos One. 14(1), 10-1371.
    87.Zhou L, Thieret R, Watzlaf V, Dealmeida D, Parmanto B. (2019) A Telehealth Privacy and Security Self-Assessment Questionnaire for Telehealth Providers: Development and Validation. Published , Int J Telerehabil 11(1), 3-14.
    88.Smith K A, Zhou L, VJM Watzlaf. (2017) User Authentication in Smartphones for Telehealth. Published , Int J Telerehabil 9(2), 3-12.
    89.Hale T M, Kvedar J C.Privacy and Security Concerns in Telehealth. , AMA Journal of Ethics 16(12), 981-985.
    90.Arora S, Yttri J, Nilse W.. Privacy and Security in Mobile Health (mHealth) Research. Alcohol Res 36(1), 143-151.
    91.Sankaranarayanan J, Murante L J, Moffett L M.A retrospective evaluation of remote pharmacist interventions in a telepharmacy service model using a conceptual framework. , Telemed J E Health 20(10), 893-901.
    92.Nittari G, Khuman R, Baldoni S, Pallotta G, Battineni G et al. (2020) Telemedicine Practice: Review of the Current Ethical and Legal Challenges. , Telemed J E 12, 10-1089.
    93.Koumaditis K, Themistocleous M, Morabito V. (2013) New Trends in Healthcare Information Systems (HIS) Integration. Handbook of Research on ICTs for Human-Centered Healthcare and Social Care Services. 784-801.
    94.J Pharm Technol.. 32(6), 227-229.
    95.Telehealth.Applications From a Legal and Regulatory Perspective. , P T 41(9), 567-570.
    96.Bashshur R L, Shannon G, Krupinski E A, Grigsby J.Sustaining and realizing the promise of telemedicine. , Telemed J E Health 19(5), 339-345.
    97.Zhao M, Hamadi H, Haley D R, Xu J, White-Williams C et al. (2020) Advances in Alternative Payment Models. Telemedicine and e-Health. 10-1089.
    98.Gilman M, Stensland J. (2013) Telehealth and Medicare: payment policy, current use, and prospects for growth. Published , Medicare Medicaid Res Rev 3(4), 10-5600.
    99.Osterweil D.Telehealth Is Ready, Payment System Isnt. Caring for the Ages. 10(11), 10-1016.